Lisata Therapeutics (8NE.F) Q2 2024 Earnings

9MayConfirmed
Q2 2024
-0.67
-0.65
-0.63
-0.6

Details

Expected EPS
-0.67222
Actual EPS
-0.60268
Surprise EPS
0.07
Surprise Percent
+10.34%

Description

Lisata Therapeutics (8NE.F) has reported earnings of -0.60268 per share for Q2 2024.

0 Comments

Share your thoughts